Hospital or health organisation · founded 1889
Mayo Clinic in Arizona
Scottsdale, United States · mayoclinic.org/patient-visitor-guide/arizona
Part of Mayo Clinic
- Citations, last 5 years
- 70k
- Works, last 5 years
- 10.5k
- h-index
- 588
- Scientists listed
- 300
- Grants since 2016
- 386
Grants received
2017–2019 · cooperative agreement · UH2
Development of Mantle Cell Lymphoma Proliferation Signature Assay
Lisa Rimsza · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2019 · research · R21
Imaging Functionally Distinct Eosinophil Subtypes Within Tissue Biopsies Using Gene Expression Profiling and an In Situ Hybridization Approach based on a Concurrent Multiple RNA Targeting Strategy
Elizabeth A Jacobsen · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · research · R01
Hemorrhage control in the irreversible anticoagulated patient
Rahmi Oklu · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2019 · cooperative agreement · U54
Overcoming Drug Resistance in Multiple Myeloma
Alexander Keith Stewart · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
Leland Hu · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2025 · research · R01
Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure
Robert Ardecky · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2020 · research · R00
Metabolic reprogramming in pluripotent induction and cardiac lineage specificatio
Clifford D Folmes · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2023 · cooperative agreement · UH3
Development of Mantle Cell Lymphoma Proliferation Signature Assay
Lisa Rimsza · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2021 · research · R01
Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure
Laurence J Miller · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · cooperative agreement · U54
Overcoming Drug Resistance in Multiple Myeloma
Peter Leif Bergsagel · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · research · R01
Hemorrhage control in the irreversible anticoagulated patient
Rahmi Oklu · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · research · R01
Hemorrhage control in the irreversible anticoagulated patient
Rahmi Oklu · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2021 · research · R01
Gastrointestinal Safety of Antithrombotic Drug Regimens
Neena S Abraham · Mayo Clinic in Arizona · funded by Agency for Healthcare Research and Quality
2017–2023 · cooperative agreement · U01
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
Leland Hu · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
Overcoming Drug Resistance in Multiple Myeloma
Peter Leif Bergsagel · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
Leland Hu · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2021 · research · R01
Targeted chemotherapy delivery and capture
Ali Khademhosseini · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2021 · research · R01
Targeted chemotherapy delivery and capture
Ali Khademhosseini · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2021 · research · R01
Targeted chemotherapy delivery and capture
Ali Khademhosseini · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2025 · research · R01
Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure
Robert Ardecky · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2022 · cooperative agreement · U01
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
Leland Hu · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2026 · research · R01
Activation of the Secretin Receptor as a Strategy for the Treatment of Heart Failure
Robert Ardecky · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
Admin Core
Peter Leif Bergsagel · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
Project 1 - High Throughtput Drug Screening and Correlations with Mutational Status in Myeloma Cell Lines and Patient Samples
Peter Leif Bergsagel · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
Project 3 - Modeling Proteasome Inhibitor Response and Resistance in Cell Lines and Patient Samples with Single Cell Analysis of Subpopulations
Brian G Van Ness · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
Admin Core
Peter Leif Bergsagel · Mayo Clinic in Arizona · funded by National Institutes of Health
2017–2023 · cooperative agreement · U54
Project 2 - IMiD Resistance in Patients and Humanized Mice with Multiple Myeloma
Shaji Kunnathu Kumar · Mayo Clinic in Arizona · funded by National Institutes of Health
2016–2019 · research · R21
Catheter guided endovascular electric field ablation for thrombosis therapy.
Ali Khademhosseini · Mayo Clinic in Arizona · funded by National Institutes of Health
2016–2019 · research · R21
Toward new classification criteria for mild and moderate TBI by a data-inclusive cross-study analysis using FITBIR
Jing Li · Mayo Clinic in Arizona · funded by National Institutes of Health
2016–2018 · research · R01
Regulation of Hepatic Lipid Accumulation and Insulin Resistance
Jun Liu · Mayo Clinic in Arizona · funded by National Institutes of Health
2016–2027 · research · R01
Mechanisms of IL-33 secretion in allergic diseases
Hirohito Kita · Mayo Clinic in Arizona · funded by National Institutes of Health
2016–2020 · research · R01
TROY HTS Compound Screening
Nhan L Tran · Mayo Clinic in Arizona · funded by National Institutes of Health
2016–2020 · research · R01
Regulation of hepatic lipid accumulation and insulin resistance
Jun Liu · Mayo Clinic in Arizona · funded by National Institutes of Health
2016–2019 · research · R01
TROY HTS Compound Screening
Nhan L Tran · Mayo Clinic in Arizona · funded by National Institutes of Health
2016–2019 · research · R01
TROY HTS Compound Screening
Nhan L Tran · Mayo Clinic in Arizona · funded by National Institutes of Health
2016 · research · Research
Comparing Two Ways to Manage Symptoms for Patients Who Have Chronic Migraine and Frequent Medication Use -- The MOTS Trial
Todd J. Schwedt · Mayo Clinic in Arizona · funded by Patient-Centered Outcomes Research Institute
2016–2027 · research · R01
Mechanisms of IL-33 secretion in allergic diseases
Hirohito Kita · Mayo Clinic in Arizona · funded by National Institutes of Health
2016–2018 · research · R21
Catheter guided endovascular electric field ablation for thrombosis therapy.
Ali Khademhosseini · Mayo Clinic in Arizona · funded by National Institutes of Health
2016–2019 · research · R01
High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1
Douglas Faigel · Mayo Clinic in Arizona · funded by National Institutes of Health
2016–2019 · research · R01
High Throughput Screening to Discover Chemical Inhibitors of Quiescin Sulfhydryl Oxidase 1
Douglas Faigel · Mayo Clinic in Arizona · funded by National Institutes of Health